
Early antivirals key to managing H1N1 in high-risk patients
The story in brief
Early antiviral use is critical for managing H1N1, especially for patients with chronic conditions like COPD, heart disease, or diabetes, which impair lung function and immune response. Delayed treatment risks ICU admission, as the therapeutic window closes rapidly. Antibiotics are ineffective, and timely oseltamivir administration within 48 hours is key to preventing severe complications.